Catalyst‐Free, Divergent Cysteine Modification via Indole Isocyanide Photochemistry
Angewandte Chemie International Edition · 08.06.2026 · 65 (24)
DOI: 10.1002/anie.202524506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 24.04.2026. Verfasst von Han Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Cysteine, Indoles, Cyanides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Key Scientific Research Project of Colleges and Universities in Henan Province, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Chemoselective cysteine modification is pivotal for chemical biology and drug discovery. While photochemical strategies offer spatiotemporal control, most current methods rely on exogenous catalysts, complicating purification processes. Furthermore, the structural diversity of accessible conjugates remains limited. Here, we report an additive/catalyst‐free, visible‐light‐driven platform for divergent cysteine modification via indole isocyanide photochemistry. This strategy eliminates the need for external additives or photocatalysts, ensuring excellent biocompatibility and operational simplicity. A key practical advantage of this method is its compatibility with both solution‐phase and solid‐phase reaction systems, offering unmatched flexibility for diverse experimental setups. By leveraging the tunable structure of indole isocyanides, this photoreaction readily generates a diverse array of indole‐fused or indole‐spiro aza‐cycles at cysteine residues. We demonstrate broad utility of this method, ranging from site‐specific modification of peptides and proteins to the synthesis of cyclic peptides and the assembly of proteolysis‐targeting chimeras (PROTACs). Moreover, a chemical proteomics profiling employing indole isocyanide‐based photoprobe achieved selective modification of C77 within the therapeutic phosphatase target PPP5C. This interaction revealed a novel druggable pocket at the TPR–catalytic domain interface, uncovering a previously unknown allosteric inhibition strategy. Collectively, this work establishes a robust, versatile platform for advancing therapeutic discovery and chemical biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Henan Key Laboratory of Precision Clinical Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Förderung
- Key Scientific Research Project of Colleges and Universities in Henan Province
- Natural Science Foundation of Henan Province
Zitieren
APA
Wei, H., Zhu, G., Zhu, R., Miao, R., Lu, X., Cheng, W., & Tian, X. (2026). Catalyst‐Free, Divergent Cysteine Modification via Indole Isocyanide Photochemistry. Angewandte Chemie International Edition, 65(24). https://doi.org/10.1002/anie.202524506
Vancouver
Wei H, Zhu G, Zhu R, Miao R, Lu X, Cheng W, et al. Catalyst‐Free, Divergent Cysteine Modification via Indole Isocyanide Photochemistry. Angewandte Chemie International Edition. 2026;65(24). doi:10.1002/anie.202524506
BibTeX
@article{Wei2026,
author = {Wei, Han and Zhu, Guanghe and Zhu, Ruiying and Miao, Ruoyang and Lu, Xinyu and Cheng, Weiyan and Tian, Xin},
title = {Catalyst‐Free, Divergent Cysteine Modification via Indole Isocyanide Photochemistry},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {24},
doi = {10.1002/anie.202524506}
}
EUVIMED